Background Endoscopic submucosal dissection (ESD) enables en bloc resection of early gastrointestinal cancers and provides ...

A multicenter clinical trial led by UTHealth Houston has found that survivors of aortic dissection can participate in ...

1. Upfront sentinel lymph node biopsy permitted the avoidance of axillary lymph node dissection in most patients with cN1 HR+/HER2- breast cancer and limited ultrasound findings. 2. Sentinel lymph ...

The 3-year axillary RFS rate was 99.2% with axillary lymph node dissection and 98.8% with less-invasive procedures. Less-invasive lymph node procedures are noninferior to axillary lymph node ...

Limited data are available on survival outcomes after sentinel-lymph-node biopsy alone as compared with lymphadenectomy in cervical cancer. In this multicenter, randomized, noninferiority trial, we ...

Response-guided axillary treatment using an approach known as the MARI protocol can safely spare many women with node-positive breast cancer from axillary lymph node dissection (ALND) after ...

Breast cancer is one of the most common malignancies in women, accounting for a large number of deaths worldwide each year. Sometimes, an essential part of breast cancer management includes an ...

Following propensity score matching, the comparative results between the two groups remained statistically non-significant. The five-year axillary recurrence-free survival (ARFS) rate was 99.2% for ...

Dr. Ko Un “Clara” Park and Dr. Mylin Torres present the latest evidence-based changes to the SLNB in early-stage breast cancer guideline. They discuss the practice-changing trials that led to the ...

Targeted axillary dissection (TAD) emerged as the optimal minimally invasive technique, demonstrating superior diagnostic accuracy over other approaches in patients with node-positive breast cancer ...

High Omega-3, Low Omega-6 Diet With Fish Oil for Men With Prostate Cancer on Active Surveillance: The CAPFISH-3 Randomized Clinical Trial These results are similar to those in patients undergoing ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...